Removal of the tumour by RCC of kidney cancer patients

Radical surgical removal of localised tumor is the only potentially curative treatment of Renal cell carcinoma (RCC). The aim is to achieve a complete removal of the tumour, with a wide surgical margin of normal tissue. Partial removel of the affected kidney with an adequate margin of normal kidney is increasingly being used as primary surgical therpy for patients with small tumour less than 4cm in size.

Other therapeutic approaches being explored for treatment of small renal cancer include use of cryoablation, high intensity focused ultrasound scan and radiofrequency ablation. About a third of the patients with RCC will present with disseminated disease. The prognosis for advance RCC is generally poor. The five year survival rate is typically less than ten percent. UP to recent times, RCC has been known to be among the most resistant to any form of chemotherapy.

New treatment of kiney cancer

Kidney cancer is one of the more common cancers that affect the urinary system. more than eighty percentage of all kidney cancer are renal cell carcinoma. Over the past few decades, there appears to be an increasing trend worldwide, Rcc occurs and has a male to female ratio 2 to 1. It is now well established that renal cell carcinoma does not represent a single disease linked to many difference genetic abnormalities.

Cigretter smokeing has been consistenly implicated and cigarette smokers have more than twice the risk of developing RCC. The sign and symptoms are that more than 60% of patients present with gross haematuria ( blood in the sugar ), back pain, abdominal mass or anaemia. Symptoms arising from metastatic disease such as shortness of breath, cough, fits, hradache and bone pain are found in thirty percentage of the patients.

Currently with routine use ultrasound and CT scans, many renal tumors are detected incidentally. Out of the 169 RCC cases operated, as mentioned above, 65% were men and 35% were female.